SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs Study Watch

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

Study Watch

by Verily Life Sciences

AI Verdict

Tool A is a diagnostic aid for physicians, leveraging AI to analyze acoustic heart signals from an electronic stethoscope to differentiate heart murmurs. In contrast, Tool B is a wearable device designed for continuous physiological monitoring in clinical research, collecting various data like ECG and heart rate. While both utilize AI in cardiology, their distinct functionalities and primary use cases make them adjacent rather than direct competitors.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if your primary need is real-time, AI-powered assistance for physicians at the point of care to quickly differentiate between physiological and pathological heart murmurs during a patient examination. This mobile application is ideal for enhancing diagnostic accuracy and providing immediate decision support when auscultating heart sounds with an electronic stethoscope.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose Study Watch if…

Choose Verily Study Watch if your objective is to conduct clinical research requiring continuous, long-term physiological monitoring of participants for data collection and analysis. This prescription-only wearable device is designed for non-invasive, extended data capture of metrics like ECG and heart rate, making it suitable for studies focused on trends, patterns, and outcomes over time rather than immediate diagnostic aid.

View Study Watch →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	Study Watch
Pricing	Contact for pricing	Not publicly available (device for clinical research and partnerships)
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Cloud (data uploaded from device to Verily's cloud platform).
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

SensiCardiac Mobi offers a mobile application for real-time diagnostic assistance during auscultation, directly integrating into a physician's immediate workflow. Study Watch, while designed for patient comfort and long-term wearability for research, serves a different purpose of continuous monitoring. Tool A's direct, interactive diagnostic support at the point of care provides more immediate and practical usability for clinicians in a diagnostic setting.

Clinical Value

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Both tools are FDA-cleared. SensiCardiac Mobi provides immediate, AI-powered decision support for differentiating heart murmurs, directly enhancing diagnostic accuracy at the point of care for a specific clinical task. Study Watch focuses on continuous physiological monitoring for clinical research, providing valuable data for long-term insights and accelerating research, but its direct clinical impact on immediate diagnosis or treatment is less explicit than Tool A.

Pricing & Value

Tie

Neither SensiCardiac Mobi nor Study Watch provides publicly available pricing information, making a direct comparison of cost impossible. Both offer significant value in their respective domains: SensiCardiac Mobi in immediate diagnostic support, and Study Watch in comprehensive data collection for clinical research. Without transparent pricing, a definitive winner cannot be determined for overall pricing and value.

Enterprise Readiness

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

SensiCardiac Mobi deploys in a hosted server environment with a mobile application, offering a potentially controlled and secure setup for healthcare organizations. While Study Watch leverages a cloud platform for data processing, which typically offers greater scalability, ongoing lawsuits alleging HIPAA and BAA breaches against Verily (Tool B's company), despite denials, introduce significant risk and compliance concerns for enterprise adoption, making Tool A a safer choice from a risk perspective.

Innovation

Study Watch

SensiCardiac Mobi innovates by applying AI to acoustic heart signals for real-time, mobile-based heart murmur diagnosis, providing a targeted clinical decision support tool. Study Watch demonstrates broader innovation through its multi-sensor wearable for continuous physiological monitoring, combined with cloud-based AI for analysis in clinical research, pushing the boundaries of long-term, comprehensive health data collection and precision health initiatives.

Support & Docs

Study Watch

Both tools provide user manuals and instructions for use. However, Verily's Study Watch explicitly mentions user experience designers and formative studies to ensure its Instructions for Use (IFU) are well-comprehended by both patients and healthcare professionals, and also details a web portal for HCPs to view data. This indicates a more comprehensive and user-centric approach to documentation and support for different user groups.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	Study Watch
Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	Study Watch
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	Verily Life Sciences
Categories	Cardiology AI, Clinical Decision Support & Reference	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Neurology, Sleep Medicine
Key Function	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.	Non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform.

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and Study Watch.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do SensiCardiac Mobi and Verily Study Watch integrate into a physician's daily clinical workflow, and for what primary clinical purpose is each designed?

SensiCardiac Mobi is designed as a point-of-care diagnostic aid, assisting physicians in real-time heart murmur differentiation during auscultation by analyzing acoustic heart signals from an electronic stethoscope. The Verily Study Watch, a prescription-only wearable, is primarily for non-invasive, continuous physiological monitoring in clinical research settings, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform.

For which specific medical specialties and patient populations are SensiCardiac Mobi and Verily Study Watch most appropriate?

SensiCardiac Mobi is best suited for cardiologists, internal medicine physicians, and pediatricians who need to quickly differentiate between physiological and pathological heart murmurs. The Verily Study Watch is utilized in cardiology, neurology, and sleep medicine, primarily for research studies requiring continuous physiological data from patients.

What level of accuracy can physicians expect from SensiCardiac Mobi in heart murmur diagnosis, and what types of data utility does the Verily Study Watch provide for clinical research?

SensiCardiac Mobi's AI algorithm is designed to distinguish between normal and pathological heart murmurs and identify S1, S2, and suspected murmurs, serving as decision support. The Verily Study Watch collects continuous data from multiple physiological sensors, including ECG, heart rate, and movement, which is then processed in a cloud platform using algorithms and machine learning for research analysis.

What is the estimated learning curve for physicians and their staff to effectively use each tool, and how quickly can a practice realize value?

SensiCardiac Mobi, as a mobile application used with an electronic stethoscope, likely has a relatively short learning curve for physicians already performing auscultation, offering immediate diagnostic support. The Verily Study Watch involves patient wearable deployment and cloud data access, suggesting a learning curve related to patient onboarding and data interpretation within the Verily cloud platform, with value realized through ongoing research data collection and analysis.

Beyond standard compliance, what specific security measures protect patient data in each tool, and what audit-trail features are available for accountability?

SensiCardiac Mobi operates within a hosted server environment (Linux OS), but specific security measures beyond HIPAA are not detailed. The Verily Study Watch features internal data storage and encryption on the device, with data processed in Verily's cloud platform, and Verily states it conducts independent audits, though specific audit-trail features for physicians are not explicitly mentioned.

What are the capabilities for integrating data from SensiCardiac Mobi and Verily Study Watch into existing Electronic Health Record (EHR) systems?

SensiCardiac Mobi, being a mobile application for real-time diagnosis, does not explicitly mention direct EHR integration, suggesting data might require manual entry or export. The Verily Study Watch uploads data to Verily's cloud platform, and Verily's Pre platform, which integrates with Samsung Galaxy Watch data, is built on a FHIR-native approach to blend complex data into actionable evidence, aiming to accelerate and improve clinical research.

What are the key considerations for deploying each of these tools across multiple clinical sites or research centers?

For SensiCardiac Mobi, multi-site rollout would involve distributing the mobile application and ensuring each site has compatible, user-provided electronic stethoscopes. For the Verily Study Watch, deployment across multiple sites would require managing the distribution and patient onboarding for the wearable devices, as well as establishing secure access and data management protocols for Verily's cloud platform for each site.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION or Study Watch

Backers

Who funded each tool's parent company.